Your session is about to expire
← Back to Search
Device
Rehabilitation for Stroke (VNS-REHAB Trial)
N/A
Waitlist Available
Research Sponsored by MicroTransponder Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
History of unilateral supratentorial ischemic stroke that occurred at least 9 months but not more than ten 10 years prior to enrollment.
Age >22 years and <80 years.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up v7, 90 days after 6-weeks of therapy
Awards & highlights
VNS-REHAB Trial Summary
This trial is testing a new treatment for people with paralysis caused by stroke. The treatment is vagus nerve stimulation during rehabilitation, and the trial will compare it to the standard-of-care rehabilitation treatment.
Eligible Conditions
- Stroke
- Weakness of the Upper Extremity
VNS-REHAB Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowVNS-REHAB Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ v7, 90 days after 6-weeks of therapy
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~v7, 90 days after 6-weeks of therapy
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Upper Extremity
Fugl-Meyer Assessment, Upper Limb (FMA-UE) Response
Wolf Motor Function Test (WMFT) Average Change
VNS-REHAB Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: VNS + Rehabilitation (1)Experimental Treatment2 Interventions
Study treatment is vagus nerve stimulation (VNS) delivered during rehabilitation.
Group II: Control VNSActive Control1 Intervention
Active control treatment is rehabilitation (standard-of-care treatment) with only a minimal amount of VNS at the start of each session intended to support blinding.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Paired Vagus Nerve Stimulation
2017
N/A
~110
Find a Location
Who is running the clinical trial?
ResearchPoint GlobalOTHER
2 Previous Clinical Trials
1,754 Total Patients Enrolled
MicroTransponder Inc.Lead Sponsor
7 Previous Clinical Trials
1,236 Total Patients Enrolled
3 Trials studying Stroke
188 Patients Enrolled for Stroke
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger